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1. Introduction 
Myocarditis is an acute or chronic inflammatory process that affects the myocardium in 
response to the action of various infectious, chemical or physical agents. In most patients the 
disease is self-limiting. The natural course of myocarditis varies greatly, ranging from an 
asymptomatic state secondary to local inflammation, through development of dilated 
cardiomyopathy with a variable course, to fatal heart failure due to disseminated 
myocarditis [Subinas et al., 2005]. 
In patients infected with human immunodeficiency virus (HIV) cardiovascular abnormalities 
are frequent but clinically discrete. Cardiologists and physicians throughout the world are 
increasingly reporting cardiac muscle disease in association with HIV. With current advances 
in HIV and acquired immunodeficiency syndrome (AIDS) management and increased 
survival, cardiac manifestations of HIV disease including HIV related myocardial disease will 
become more important and will be encountered more frequently. Because cardiac 
complications in HIV positive patients are often clinically inapparent, periodic screening of 
these patients is recommended, especially in those with low CD4 counts or receiving treatment 
with cardiotoxic drugs. The heart may be a marker of the HIV infected patient’s overall health, 
and a decline in cardiac function should trigger more comprehensive evaluation. As the role of 
infection and inflammation in many other cardiovascular diseases is now recognized, 
identification of the molecular mechanisms of HIV related myocaditis might have broader 
implications for a wide range of patients [Azis F et al., 2010]. 
The diagnosis of myocarditis in HIV positive patients during an acute episode may prove 
difficult, due to the lack of diagnostic techniques with acceptable degrees of specificity and 
sensitivity. For these patients although endomyocardial biopsy is still considered the 
diagnostic gold standard, the developments of new imaging techniques, such as cardiac 
magnetic resonance imaging (CMR), and nuclear imaging by antimyosin scintigraphy have 
contributed greatly to the diagnosis of myocarditis. 
2. Myocarditis in HIV positive patients 
HIV infection and AIDS have a well-recognized association with myocarditis and dilated 
cardiomyopathy [Azis F et al., 2010]. This increased predisposition is multifactorial and may 
include the direct effects of HIV itself, co-infection by opportunistic organisms, toxic effects 
of commonly used medications or illicit drugs, and nutritional deficiencies [Azis F et al., 
2010]. Further, autoimmunity can be an important contributor to the pathogenesis of 
cardiomyopathy in these patients as many studies demonstrated the presence of cardiac-
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specific antibodies in HIV positive patients when compared with HIV negative controls 
[Currie & Boon 2003, Currie et al., 1998]. Thus, although the precise mechanisms are poorly 
understood, alterations in the immune system likely play an important role in the 
pathogenesis of heart muscle disease in HIV-infected patients. The prevalence of 
myocarditis in HIV infected patients has been difficult to establish with estimates ranging 
from 6% [Barbaro et al., 1998b] to 52% [Levy et al., 1989]. In other studies about 10 percent of 
people with HIV develop myocarditis, either because HIV directly invades the heart muscle 
or because the patient’s weakened immune system makes the heart muscle more susceptible 
to attack by other infectious agents, especially toxoplasmosis [Grange et al., 1990, Matturi et 
al., 1990]. 
HIV deserves special mention because it seems to function differently than other viruses. 
HIV-1 glycoprotein 120 can directly disrupt cardiac contractility without any inflammatory 
response [Currie & Boon, 2003]. This may explain why HIV genomes can be amplified from 
patients without histologic signs of inflammation. Myocarditis is the most commonly 
cardiac abnormality found on biopsy tissue, present in some degree, in more than 50% of 
HIV patients [Howes et al., 2010]. In addition, in patients who are infected with HIV, T-cell – 
mediated immune suppression increases the risk of contracting myocarditis due to other 
infectious causes [Howes et al., 2010]. 
2.1 Etiology 
The actual pathogenesis of cardiac injury in HIV infection is not clear. It is however 
generally agreed that several factors come into play either singly or in combination to 
produce cardiac pathology [Aziz 2010]. There is a wide range of hypotheses regarding the 
pathogenesis of HIV associated heart muscle disease. These include myocardial invasion 
with HIV itself, opportunistic infections, viral infections, and autoimmune response to viral 
infection, drug-related cardiac toxicity, nutritional deficiencies, endothelial dysfunction, 
autonomic dysfunction, and prolonged immunosuppression. Zidovudine (AZT), an 
antiretroviral drug used in treatment of HIV, has also been associated with myocarditis 
[Herskowitz et al., 1992a]. 
Opportunistic infections are common complications of AIDS and the most frequent 
cause of morbidity and mortality. However, relatively few pathogens have been 
isolated from the myocardium of AIDS patients [Olson 2003]. Myocardial involvement 
is usually associated with disseminated disease and multiple foci of infection. Typically, 
infectious organisms are identified in patients dying of noncardiac causes, and the 
findings of myocardial abnormalities are regarded as incidental. Opportunistic 
pathogens represent diverse causes of infectious disease, including bacteria, fungi, 
protozoa, and viruses [Olson 2003]. 
Toxoplasma gondii (T gondii) is the most frequently documented infectious cause of 
myocarditis associated with AIDS, and the heart is the second most common site of infection 
after the brain. Autopsy series have described T gondii myocarditis (myocardial 
toxoplasmosis) in 1% to 16% of patients dying of AIDS [Baroldi et al., 1988, Anderson et al., 
1988, Matturi et al., 1990]. Evidence of myocardial toxoplasmosis includes trophozoites or 
pseudocysts in myocardial fibers. A minority of cases has associated myocarditis with focal 
areas of necrosis and lymphocytic infiltrates [Jautzke 1993]. Antemortem diagnosis of 
toxoplasma myocarditis associated with left ventricular (LV) dysfunction has been 
described, including its successful treatment [Grange et al., 1990, Albrecht et al., 1994].  
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Pericardial tuberculosis has been reported in association with AIDS, typically in the setting 
of widespread disease. However, myocardial tuberculosis appears rare [Miller-Catchpole et 
al., 1989, Kinney et al., 1989]. 
Fungal myocarditis is an unusual complication of disseminated infection that is identified 
most often at autopsy [Olson 2003]. Various fungal organisms identified in the myocardium 
at autopsy with associated myocarditis have included Aspergillus  fumigatus, Candida albicans, 
Histoplasma capsulatum, Coccidioides immitis, and Cryptococcus neoformans.  Cardiac 
cryptococcus has been diagnosed in association with congestive heart failure and shown to 
resolve after therapy with amphotericin B and flucytosine [Kinney et al., 1989, Lewis et al., 
1985, Lafont et al., 1987].  
Several viruses have been implicated in myocarditis associated with AIDS. Cytomegalovirus 
(CMV) is a common opportunistic pathogen in AIDS, but it is associated less frequently with 
myocarditis [Michaels et al., 1997]. When inclusion bodies are the criterion for the detection 
and diagnosis of solid organ involvement by CMV, the rate of infection is underestimated 
compared to in situ DNA hybridization techniques [Wu et al., 1992, Myerson et al., 1984]. 
Other viruses identified by culture or polymerase chain reaction (PCR) within the 
myocardium of HIV-infected or AIDS patients, either at antemortem endomyocardial 
biopsy or from autopsy material, have included Epstein-Barr and coxsackie B virus in adults 
[Barbaro et al., 1988a] and adenovirus in children [Bowles et al., 1999]. These viruses may be 
present as either primary infection or as coinfection and can occur with or without 
associated myocarditis and with or without associated LV dysfunction. 
2.2 Pathogenesis 
The first clinical report to suggest a relationship between nonspecific myocarditis and 
dilated cardiomyopathy in AIDS patients appeared in 1986 [Cohen et al., 1986]; 3 patients 
had clinical, echocardiographic, and pathologic findings of dilated cardiomyopathy and 2 of 
the patients had focal lymphocytic infiltration associated with myocyte necrosis. Subsequent 
reports suggested an association between focal nonspecific myocarditis at autopsy and 
clinical cardiomyopathy [Barbaro et al., 1998a, Reilly et al., 1988]. Numerous hypotheses 
have been suggested to account for the etiology of nonspecific myocarditis and 
cardiomyopathy observed in HIV-infected patients, including direct HIV-1 infection of 
myocardial cells or coinfection with other cardiotropic viruses, [Olson 2003] cytokine 
cardiotoxicity [Suffredini et al., 1989, Lahdevirta et al., 1988, Levine et al., 1990], postviral 
cardiac autoimmunity [Herskowitz et al., 1989, 1993], nutritional deficiencies [Olson 2003], 
and cardiotoxicity due to illicit drugs [Olson 2003] or pharmacologic agents [Herskowitz et 
al., 1992a, Olson 2003]. 
The histologic findings of a monoclonal or oligoclonal inflammatory cellular infiltrate 
suggest a viral or autoimmune cause for the myocarditis associated with HIV infection. 
Myocarditis is more likely in individuals with more profound immunosuppression because 
CD4 < 400 cells/µL is more frequently observed in patients with dilated cardiomyopathy 
[Barbaro et al., 1998b]. In this same series, inflammatory myocardial cellular infiltrates were 
predominantly CD3 lymphocytes in 12 patients and CD8 lymphocytes in 64 patients. A 
separate report [Herskowitz et al., 1992b] described 35 HIV-infected patients with global LV 
dysfunction who underwent endomyocardial biopsy in which active or borderline 
myocarditis was observed in 55% of patients. For those patients with biopsy-proven 
myocarditis, mean LV ejection fraction was 28% whereas for patients without myocarditis it 
was 48%. The cellular infiltrate was primarily composed of CD8 T lymphocytes. 
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Although it has been suspected that myocarditis and cardiomyopathy associated with HIV-
1 infection may be caused by direct viral infection of myocytes, definite evidence for this is 
lacking. Difficulty in demonstration of a link among HIV-1 infection, myocarditis, and 
cardiomyopathy in AIDS is related, in part, to lack of a suitable in vivo model of the disease. 
Because of the limited host range of HIV-1 and the difficulty in handling nonhuman 
primates infected with simian immunodeficiency virus-1, little investigation has been 
reported of myocarditis or cardiomyopathy associated with AIDS in animal models [Lewis 
et al., 2000]. 
What is the potential for direct myocardial infection? HIV-1 invades T cells by attachment to 
a CD4 surface-membrane receptor.  However, there are no CD4 receptors on myocyte 
surface membranes. It is possible that the virus gains access to myocytes by other 
mechanisms, although the evidence to support this concept is limited. It is also possible that 
injury to myocytes may facilitate entry of the HIV virion; Epstein-Barr virus (EBV) promotes 
entry of HIV into CD4 receptor negative cells, with subsequent replication [Olson 2003]. 
The presence of viral genomic material within the myocytes of HIV-infected patients with 
myocarditis and cardiomyopathy does not definitely establish viral infection as causal. 
Furthermore, the significance of the finding of viral transcripts within cells is uncertain 
because patients may or may not have LV dysfunction [Herskowitz et al., 1993]. HIV-1 
genomic material reportedly was detected within the genome of myocardial cells, although 
typically the findings have been sparse and may not have represented myocyte infection 
because the HIV nucleic acid sequence may actually have been located in endothelial cells or 
macrophages [Grody et al., 1990, Lipshultz et al., 1990, Flomenbaum et al., 1989, Cenacchi et 
al., 1990]. 
In one study, in 58 of 63 patients with AIDS, LV dysfunction, and biopsy-proven nonspecific 
lymphocytic myocarditis, a positive hybridization signal was observed but staining was 
weak and affected myocytes were generally not surrounded by inflammatory cells [Barbaro 
et al., 1998a]. 
In adults with AIDS-associated myocarditis, non-HIV viruses or viral genomic material 
identified in myocardial tissue has included CMV, Coxsackie virus group B, and EBV 
[Barbaro et al., 1998b, Wu et al., 1992]. In an autopsy study of 32 children who died with 
advanced HIV disease, including 23 with histologic evidence of myocarditis, viral sequences 
detected by polymerase chain reaction included adenovirus in 6, CMV in 3, and both 
adenovirus and CMV in 2. No other viruses were detected by polymerase chain reaction, 
including HIV [Bowles et al., 1999]. 
A high proportion of HIV-seropositive patients with LV dysfunction have evidence of latent 
infection of myocytes with CMV immediate-early genes [Wu et al., 1992]. Although 
observation of the intranuclear inclusions of active, lytic CMV infection is unusual, it has 
been suggested that latent viral infection may promote enhanced major histocompatibility 
complex expression, thereby provoking immune-mediated injury typical of animal models 
of myocarditis [Wu et al., 1992]. 
Immune-mediated mechanisms other than direct myocardial viral infection may account for 
the cellular infiltrates and cardiomyopathy observed in AIDS patients. Studies performed by 
Herskowitz demonstrated circulating autoantibodies in 4 of 6 AIDS patients with 
cardiomyopathy, whereas AIDS patients without cardiomyopathy did not have these 
antibodies [Herskowitz et al., 1989]. In the patients with autoantibodies, antimyosin 
antibodies were identified. In these same individuals, no evidence of HIV-1 or other viruses 
was identified from myocardial biopsy specimens evaluated by in situ hybridization, 
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lending support to an autoimmune mechanism of disease. A study by Gu et al. [Gu et al., 
1992] used monoclonal antibodies to HIV core proteins that reacted with myocyte antigens 
in 38 of 42 AIDS patients (and 11 of 28 non-AIDS patients), suggesting antibodies occurring 
in AIDS patients may react with antigenic epitopes of myocytes, thereby promoting 
autoimmune-mediated heart muscle disease. 
Multiple cytokines are suspected of having a role in the mediation of myocardial 
inflammation, myocyte necrosis and ventricular dysfunction in myocarditis, although 
specifics are incompletely understood in human disease [Liu et al., 2001]. The mononuclear 
cells characteristic of lymphocytic myocarditis, including the focal nonspecific myocarditis 
of AIDS, are a likely source of cytokines that promote inflammation and maintenance of 
immune response, which may lead to impaired contractile function and fibrosis. Matsumori 
et al. 1994 showed that patients with myocarditis have markedly increased concentrations of 
cytokines, including tumor necrosis factor alfa (TNF-α) and interleukin -1 and -6.  In animal 
models of myocarditis, similar profiles of cytokine activation have been described and have 
been demonstrated directly in cardiac tissue [Yamada et al., 1994]. TNF-α has been 
demonstrated to be a negative inotrope [Suffredini et al., 1989] and is increased in patients 
with congestive heart failure [Sharma et al., 2000], AIDS [Odeh et al., 1990, Yamamoto et al., 
1995], and myocarditis [Matsumori et al., 1994]. HIV may cause myocyte injury by an 
“innocent bystander destruction” mechanism, as may occur in AIDS-associated encephalitis 
[Ho et al., 1987]. However, whether these mechanisms operate in the myocarditis and 
dilated cardiomyopathy of AIDS is unknown. 
Three histological patterns of myocarditis have been described in patients with AIDS: 
- lymphocytic infiltration with myocyte necrosis [Anderson et al., 1988], which meets the 
Dallas criteria;  
- lymphocytic infiltration without inflammation [Lewis et al., 1992];  
- myocyte damage without evidence of inflammatory infiltrate [Lafontet al., 1987]. 
2.3 Clinical manifestation 
Clinical presentation of HIV associated myocarditis in symptomatic patients is generally 
similar to myocarditis due to other causes. The absence of symptoms and signs of heart 
disease does not however exclude cardiac involvement, as occurrence of sub-clinical cardiac 
abnormalities with possible fatal consequences in this population has been described 
[Kaminski et al., 1990]. Diagnosis requires the possibility of cardiac involvement to be 
constantly in mind and symptoms associated with myocarditis are varied, and relate either 
to the actual inflammation of the myocardium, or the weakness of the heart muscle that is 
secondary to the inflammation. Signs and symptoms of myocarditis include: chest pain 
(often described as “stabbing” in character); congestive heart failure (leading to edema, 
breathlessness and hepatic congestion); palpitations (due to arrhythmias); sudden death (in 
young adults, myocarditis causes up to 20% of all cases of sudden death); fever (especially 
when infectious); symptoms in infants and toddlers tend to be more non-specific with 
generalized malaise, poor appetite, abdominal pain, chronic cough. Later stages of the 
illness will present with respiratory symptoms with increased work of breathing and is 
often mistaken for asthma. 
Since myocarditis is often due to a viral illness, many patients give a history of symptoms 
consistent with a recent viral infection, including fever, rash, diarrhea, joint pains, and 
frequent fatigue. 
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Myocarditis is often associated with pericarditis, and many patients present with signs 
(pericardial friction rub) and symptoms that suggest concurrent myocarditis and 
pericarditis. 
2.4 Diagnostic 
Myocarditis refers to an underlying process that causes inflammation and injury of the 
heart. It does not refer to inflammation of the heart as a consequence of some other insult. 
Many secondary causes, such as a heart attack, can lead to inflammation of the myocardium 
and therefore the diagnosis of myocarditis cannot be made by evidence of inflammation of 
the myocardium alone.  
Myocardial inflammation can be suspected on the basis of electrocardiographic (ECG) results, 
elevated C-reactive protein (CRP) and/or erythrocyte sedimentation rate (ESR) and increased 
IgM (serology) against viruses known to affect the myocardium. Markers of myocardial 
damage (troponin or creatine kinase cardiac isoenzymes) are elevated.  
The difficulty in diagnosing myocarditis lies in the known absence of specificity and 
sensitivity of the various diagnostic techniques used. Systematic biochemical measurements 
are not diagnostic and an increase in cardiotropic virus antibodies only reflects the response 
to a recent viral infection, but does not indicate active myocarditis. Endomyocardial biopsy, 
considered to be the diagnostic gold standard, is associated with a not inconsiderable risk of 
injury, as well as with sampling errors due to the focal involvement of the myocardium, 
which therefore reduces its diagnostic sensitivity. Radioactive isotope studies, widely used 
for the diagnosis of myocarditis, are limited by their low specificity, the exposure to 
radiation, and their cost [Subinas et al. 2005]. 
2.4.1 Physical examination 
Physical findings of myocarditis can range from a normal examination, through all classes of 
congestive heart failure (CHF) to cardiovascular collapse and shock. Patients with mild 
cases of myocarditis have a nontoxic appearance and simply may appear to have a viral 
syndrome. Tachypnea and tachycardia are common. Tachycardia is often out of proportion 
to fever [Howes 2010]. 
More acutely ill patients have signs of circulatory impairment due to left ventricular failure. 
A widely inflamed heart shows the classic signs of ventricular dysfunction including the 
following: jugular venous distention, bibasilar crackles, ascites and peripheral edema. 
Third heart sound (S3) or a summation gallop may be noted with significant biventricular 
involvement. Intensity of the first heart sound (S1) may be diminished. S3 generally occur 
between 0.12 and 0.24 second after the aortic component of the second heart sound. 
Clinically, the third heart sound (S3 gallop) may be a physiologic sound in children and 
young adults. It may be produced by factors that generate increased rate or volume of flow 
with high cardiac output or by conditions associated with cardiac dilatation and altered 
ventricular compliance, as in CHF [Smiterman TC and Willerson JT, 2007]. 
Cyanosis may occur. Murmurs of mitral or tricuspid regurgitation may be present due to 
ventricular dilation [Howes 2010]. 
In cases where a dilated cardiomyopathy has developed, signs of peripheral or pulmonary 
thromboembolism may be found [Howes 2010]. 
Diffuse inflammation may develop leading to pericardial effusion, without tamponade, and 
pericardial and pleural friction rub as the inflammatory process involves surrounding 
structures [Howes 2010]. 
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2.4.2 Invasive techniques 
Cardiac angiography: This is often indicated to rule out coronary ischemia as a cause of 
new-onset heart failure, especially when clinical presentation mimics acute myocardial 
infarction. It usually shows high filling pressures and reduced cardiac outputs [Tang et al., 
2009]. 
The gold standard is still biopsy of the myocardium, generally done in the setting of 
angiography. A small tissue sample of the endocardium and myocardium is taken, and 
investigated by a pathologist by light microscopy and—if necessary—immunochemistry 
and special staining methods [Cunningham et al., 2006]. Histopathological features are: a 
myocardial interstitium with abundant edema and inflammatory infiltrate, rich in 
lymphocytes and macrophages. Focal destruction of myocytes explains the myocardial 
pump failure. The need for routine myocardial biopsy in patients with HIV is controversial 
and associated risks are significant – sensitivity is low, especially in patchy lesions, and 
beyond research protocols, its use is limited to patients with extensive cardiac damage with 
no identifiable cause [Wu et al., 1990]. 
Myocarditis identified at autopsy or on endomyocardial biopsy in HIV-infected patients is 
most often nonspecific and manifested as focal, inflammatory lymphocytic infiltrates 
without myocyte necrosis. Other reported histopathologic findings include lymphocytic 
infiltration with myocyte necrosis fulfilling the Dallas criteria or myocyte damage without 
associated cellular inflammatory infiltrate [Anderson et al., 1988, Barbaro et al., 1998]. The 
autopsy finding of focal myocarditis in many patients who die of AIDS-related 
complications, but have no known premortem heart disease, suggests that focal lymphocytic 
infiltration may have no clinical significance. By comparison, diffuse lymphocytic 
myocarditis meeting the Dallas criteria appears rare [Anderson et al., 1988]. 
The prevalence of nonspecific myocarditis is related to the stage of HIV infection and the 
presence of structural heart disease. In one study of HIV-infected patients with a pre- 
mortem diagnosis of dilated cardiomyopathy, histologic findings consistent with 
lymphocytic myocarditis by the Dallas criteria were identified in 63 of 76 patients (83%) 
[Barbaro et al., 1998].   
2.4.3 Non-invasive techniques 
Electrocardiography (ECG) is a useful screening tool in patients with HIV infection, and 
ECG changes may precede echocardiographic abnormalities. Patients with abnormal ECG 
patterns should be further investigated [Tang et al., 2009]. 
Electrocardiography is often nonspecific (eg, sinus tachycardia, nonspecific ST or T-wave 
changes). Occasionally, heart block (atrioventricular block or intraventricular conduction 
delay), ventricular arrhythmia, or injury patterns with ST- or T-wave changes mimicking 
myocardial ischemia or pericarditis (pseudoinfarction pattern) may indicate poorer 
prognosis [Gorgels 2007]. 
A chest X- ray can offer data about the size and shape of hart, as well as identification of 
fluid in or around the heart that might indicate heart failure [Round 2007].  
Echocardiography has been shown to be extremely useful for the diagnosis and monitoring 
of HIV associated myocardial disease. Echocardiography is performed to exclude other 
causes of heart failure (eg, valvular, amyloidosis, congenital) and to evaluate the degree of 
cardiac dysfunction (usually diffuse hypokinesis and diastolic dysfunction). It also may 
allow gross localization of the extent of inflammation (ie, wall motion abnormalities, wall 
thickening, and pericardial effusion). In addition, echocardiography may distinguish 
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between fulminant and acute myocarditis by identifying near-normal left ventricular 
diastolic dimensions and increased septal thickness in fulminant myocarditis (versus 
increased left ventricular diastolic dimensions and normal septal thickness in acute 
myocarditis), with marked improvement in systolic function in time [Tang et al., 2009]. 
De Castro et al., in 1994 performed a study of 136 HIV-infected patients without clinical, 
electrocardiographic or echocardiographic evidence of cardiovascular dysfunction on 
admission who were prospectively studied with serial echocardiograms; 93 of these patients 
had AIDS. During a mean follow-up period of 415 days, seven patients, all in the AIDS 
subgroup, developed clinical and echocardiographic findings of acute global left ventricular 
dysfunction; six of these seven patients died of congestive heart failure. Necropsy findings 
in five of these patients revealed acute lymphocytic myocarditis in three, cryptococcal 
myocarditis in one, and interstitial edema and fibrosis in one. 
Cardiac computed tomography (CT) can have a role in the management of the 
undifferentiated heart failure patient, principally in excluding the presence of significant 
obstructive epicardial disease using CT angiography. Current generation 64-slice scanners 
demonstrate excellent diagnostic accuracy for both proximal coronary vessels and smaller 
distal vessels [Leber et al., 2005, Raff et al., 2005, Fine et al., 2006]. These recent studies 
especially demonstrate a high (greater than 95%) negative predictive value for the exclusion 
of significant epicardial stenosis. 
Hence, although it has not been prospectively evaluated in the newly diagnosed heart 
failure population, the data would indicate that this modality can be used to stratify the 
patient with heart failure into an ischemic or non-ischemic etiology group. 
Cardiac MRI (CMR) shows the accumulation of contrast in the myocardium as a 
consequence of the breakdown of the myocyte membrane resulting from the inflammatory 
process. The uptake of contrast usually has a characteristic patchy pattern for about the first 
2 weeks after the acute event, later becoming progressively more disseminated. [Friedrich 
1998]  Moreover, this pattern of contrast uptake is easily distinguished from the 
subendocardial pattern of uptake seen in acute myocardial infarction. 
CMR with contrast in association with cine-MRI is a useful tool for the diagnosis of 
myocarditis and provides an alternative to endomyocardial biopsy. 
The availability of this diagnostic technique in the context of an acute episode might obviate 
the use of other, invasive diagnostic techniques which are not exempt from associated 
disease. 
Roditi et al., in 2000 evaluated 20 patients with T1 spin-echo cine MR angiography and 
gadolinium-enhanced spin-echo imaging. Focal myocardial enhancement was associated 
with regional wall motion abnormalities in 10 of the 12 patients with suspected or proven 
myocarditis. The authors concluded that focal myocardial enhancement combined with 
regional wall motion abnormalities (hypokinesis, akinesis, or dyskinesis) strongly supported 
a diagnosis of myocarditis. 
A combined CMR approach using T2-weighted imaging and contrast-enhanced T1-
weighted images yields high diagnostic accuracy and thus, is a useful tool in the diagnosis 
and assessment of patients with suspected acute myocarditis [Abdel-Aty et al., 2005]. 
Friedrich et al. in 1998 were the first to propose CMR for the noninvasive diagnosis of acute 
myocarditis. Using T1-weighted images, they found that the myocardium in patients with 
suspected myocarditis has greater signal intensity relative to skeletal muscle [Friedrich et al., 
1998]. T2-weighted images early after symptom onset can show focal increases of 
subepicardial and mid-wall myocardial signal, defining areas of myocardial edema [Abdel-
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Aty et al., 2005]. Late gadolinium enhancement (LGE) - CMR has been shown to have 
additional value in the detection of active myocarditis as defined by histopathology 
[Mahrholdt et al., 2004]. 
LGE in the setting of myocarditis has a “nonischemic” pattern, typically affecting the 
subepicardium and the midmyocardial wall. This focal enhancement becomes diffuse over a 
period of days to weeks, then decreases during healing and may become invisible after 
recovery [Mahrholdt et al., 2004]. Alternatively, large areas of scarring might still be visible 
after healing, causing distinctive enhancing linear mid-wall striae. CMR-guided 
endomyocardial biopsy can result in a greater yield of positive findings than routine right 
ventricular biopsy [Mahrholdt et al., 2004].  
This technique has not yet been fully evaluating in asymptomatic HIV infected subjects to 
establish the prevalence of unrecognized myocarditis. 
Nuclear imaging: Antimyosin scintigraphy (using antimyosin antibody injections) can 
identify myocardial inflammation with high sensitivity (91-100%) and negative predictive 
power (93-100%) but has low specificity (31-44%) and low positive predictive power (28-
33%). In contrast, gallium scanning is used to reflect severe myocardial cellular infiltration 
and has a good negative predictive value, although specificity is low [Tang et al., 2009]. 
In preliminary studies, a positive gallium scan improved the diagnostic yield of biopsy 
fourfold (baseline incidence of myocarditis - 8%; incidence associated with a positive scan – 
36%). Gallium is an inflammatory avid isotope, whereas antimyosin antibodies are capable 
of labeling myocytes. Because histologic myocarditis consists of active inflammation in the 
presence of myocyte necrosis, indium 111 antimyosin antibodies may be useful in detecting 
this condition [O'Connell 1987].  
Specific outcome data in HIV infected patients are missing. 
2.5 Personal contribution 
In Romania as in many other developing countries over the world cardiac MRI cannot be 
used widely for diagnosis. In the last several years within our cohort of adolescents and 
young adults HIV infected since their childhood we have noticed an increased number of 
patients with symptoms that suggest cardiac involvement. Dilative cardiomyopathy noticed 
more often in children infected by HIV was diagnosed especially postmortem at necropsy. 
As long as these patients present an increased rate of survival we are challenged to perform 
accurate diagnosis of cardiac involvement during their life.  
During the last 2 years we have the opportunity to evaluate 10 patients with HIV and 
symptoms of cardiac involvement by performing: ECG, echocardiography, and nuclear 
imaging using technetium 99 (99Tc). The 10 patients, 5 women and 5 men, were aged 
between 17 and 55 years. Echocardiography demonstrated in 4 cases normal left ventricular 
diastolic dimensions and small increases in septal thickness and in other 6 cases increased 
left ventricular diastolic dimensions and normal septal thickness. From the 4 patients with 
minimal echocardiography changes, nuclear imaging using technetium 99 showed no wall 
motions disorders and no changes in myocardial perfusions in 3 patients. In one patient we 
found no changes in echocardiography and ECG, while myocardial scintigraphy with 99Tc 
showed changes in wall motility (akinesia) at rest and on stress and ischemic areas at the 
antero-septal wall and myocardial apex (4%), while at rest the affected area by myocardial 
scintigraphy was about 2%, as we can noticed in figure no. 1 [Cambrea et al., 2009]. From 
those 6 patients who presented changes on echocardiography, nuclear imaging with 99Tc 2 
patients demonstrated dilatative cardiomyopathy with no ischemic area, as shown in figure 
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no. 2. The other 4 patients presented with dilative cardiomyopathy and ischemic areas on 
stress, as demonstrated in figure no. 3.  All 10 patients had received HAART including 
protease inhibitors for at least 5 years and significant changes in lipid profile. 
 
 
 
Fig. 1. Myocardic scintigraphy - ischemic areas at the antero-septal wall and myocardial 
apex. 
2.6 Differential diagnosis of myocarditis in HIV 
It is difficult to assess the clinical significance of viral infection of the myocardium in HIV- 
infected patients.  AIDS or HIV-infected patients with myocarditis most often present with 
signs and symptoms of congestive heart failure or asymptomatic left ventricular 
dysfunction. The diagnosis of dilatative cardiomyopathy in this setting is best established by 
echocardiography. More specific diagnosis can be established by endomyocardial biopsy, as 
clinically indicated. However, in the vast majority of cases endomyocardial biopsy will not 
identify a specific cause that will modify therapy. In a minority of patients, biopsy may 
establish a treatable cause of myocarditis. Therefore, the clinician should consider the 
specifics of each case before making a recommendation regarding whether endomyocardial 
biopsy is necessary [Olson 2003]. 
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Fig. 2. Myocardic scintigraphy - dilatative cardiomyopathy with no ischemic area. 
Aside from nonspecific or infectious myocarditis, the differential diagnosis of LV 
dysfunction in the AIDS patient includes drug toxicity from either abuse of illicit substances 
or iatrogenic disease from agents used in the therapy for AIDS.  AIDS patients often take a 
great variety of prescription and nonprescription drugs and use illicit drugs. Alcohol, 
cocaine, or heroin may contribute to LV dysfunction in many cases [Virmani et al., 1988; 
Regan et al., 1990; Soodini et al., 1991]. Pharmacotherapy is also potentially associated with 
LV dysfunction in AIDS patients. Therapeutic agents implicated as potential cardiac toxins 
include zidovudine [Herskowitz et al., 1992b; d’Amati et al., 1992], and interferon alfa-2 
[Deyton et al., 1989; Zimmerman et al., 1994]. 
If neoplastic infiltration is suspected as a cause of LV dysfunction, cardiac computed 
tomography or magnetic resonance imaging may be a useful adjunct to 
echocardiography for characterizing cardiac involvement. Neoplastic infiltration of the 
heart by Kaposi sarcoma is frequently seen at autopsy and usually associated with 
widespread disease in the terminal phases of AIDS [Silver et al., 1984]. Non-Hodgkin 
lymphoma is also observed in this setting and also associated with widespread disease 
[Holladay et al., 1992]. 
In addition to HIV-related cardiac conditions, differential diagnosis also includes non-HIV 
disease, because the latency of HIV disease may be long and patients are at risk for 
development of hypertensive heart disease, coronary artery disease, or other causes of left 
ventricular dysfunction [Olson 2003]. 
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Fig. 3. Myocardic scintigraphy - dilative cardiomyopathy and ischemic areas on stress. 
2.7 Treatment 
Treatment for HIV related myocarditis is generally similar to that for non-HIV related 
myocarditis. Symptomatic treatment is the only form of therapy for HIV positive patients 
with myocarditis. In the acute phase, supportive therapy including bed rest is indicated. For 
symptomatic patients, digoxin and diuretics provide clinical improvement. For patients 
with moderate to severe dysfunction, cardiac function can be supported by use of inotropes 
such as Milrinone in the acute phase followed by oral therapy with ACE inhibitors 
(Captopril, Lisinopril) when tolerated. Patients who do not respond to conventional therapy 
are candidates for bridge therapy with left ventricular assist devices. Heart transplantation 
is reserved for patients who fail to improve with conventional therapy. Patients with HIV 
and myocarditis have enhanced sensitivity to digoxin and anticoagulation presents risks to 
patients with cerebral vasculopathy and possible aneurysm formation [Howes et al., 2010]. 
The use of immunosuppressive regimens in these patients is controversial and no 
convincing benefits have been reported other than with intravenous immunoglobulin 
[Lipshultz et al., 1995], whose efficacy may reflect inhibition of cardiac auto antibodies by 
competition with Fc receptors or dampened effects of cytokines and cellular growth factors. 
The introduction of highly active antiretroviral therapy (HAART) regimens has 
substantially modified the course of HIV disease by lengthening survival and improving 
quality of life of HIV-infected patients [Zareba & Lipshultz 2003]. There is also good 
evidence that HAART significantly reduces the incidence of cardiovascular manifestations 
of HIV infection. By preventing opportunistic infections and reducing the incidence of 
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myocarditis, HAART regimens have reduced the prevalence of HIV-associated myocarditis 
to about 30% [Barbaro 2005]. One Italian study reported an almost 7-fold reduction of the 
prevalence of HIV-associated myocarditis from the pre-HAART era [Pugliese et al., 2000]. In 
that study there is no conclusive evidence that HAART reverses cardiomyopathy, but it 
does appear that by preventing profound immunosuppression and the development of 
AIDS, heart muscle remains healthier [Pugliese et al., 2000]. 
3. Conclusions 
Cardiac dysfunction should be considered in the differential diagnosis of any HIV-infected 
patient with dyspnea or cardiomegaly. In the setting of AIDS or HIV infection, the diagnosis 
of dilated cardiomyopathy is established by echocardiography. A significant proportion, 
perhaps exceeding 80%, of patients with dilated cardiomyopathy may have focal, non-
specific lymphocytic myocarditis [Barbaro et al., 1998a].  
Although viruses, in general, are well established as a cause of acute myocarditis, a causal 
role for viruses in the pathogenesis of dilated cardiomyopathy has not been demonstrated 
conclusively, including HIV infection.  
A low CD4 count is an excellent predictor of the presence of LV dysfunction. The risk of 
dilated cardiomyopathy may also be increased with a history of illicit drug use [Soodini et 
al., 2001].  
Myocarditis due to HIV-1 myocyte infection does not seem to be the most likely cause of LV 
dysfunction in patients with AIDS. It is more likely that the cause of LV dysfunction and 
congestive heart failure in this setting is multifactorial, related to drug toxicity, non-HIV 
viral infection, poor nutrition, or cytokines. Another situation in HIV positive patients that 
can cause myocarditis with or without ischemia is dyslipidemia as a consequence of highly 
active antiretroviral therapy that included protease inhibitor for a long period of time. 
The evaluation and management of HIV positive patients with myocarditis and specific 
dilated cardiomyopathies remains clinically challenging. Essential to the appropriate care of 
these patients is not only an understanding of the patient’s cardiac morphology and 
function but also identification of pathologic and modifiable substrate. 
The ultimate proof that the patient has myocarditis is provided by endomyocardial biopsy, 
but the patchy nature of the disease limits its diagnostic role [Karamitsos et al., 2009].  
Computed tomography or magnetic resonance imaging may help but are not widely used 
for diagnosis. Gadolinium-enhanced magnetic resonance imaging is used for assessment of 
the extent of inflammation and cellular edema, although it is still nonspecific. Delayed-
enhanced MRI has also been used to quantify the amount of scarring that occurred 
following acute myocarditis [Al-Mallah & Kwong 2009].  
By virtue of its safety, high degree of accuracy and reproducibility, and multiparametric 
nature, cardiac MRI represents the principal imaging modality that potentially addresses 
each of these points of care for heart failure patients. However, coronary CT angiography 
can aid in ruling out epicardial coronary artery stenosis as the cause of LV dysfunction in 
selected patients presenting with congestive heart failure. 
In addition to clinical examination and biological evaluation, in the absence of cardiac MRI, 
a combination of ultrasound and scintigraphic investigations of the heart can provide 
sufficient data to establish myocardial dysfunction with or without ischemia.  
Because cardiac CT, CMR and cardiac scintigraphy were not widely used in patients with 
myocarditis and in HIV cases are only sporadic presentations, to identify particular aspects 
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of myocarditis in HIV positive patients is necessary to extend these new investigational 
noninvasive methods to a large number of patients. 
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